ADAPT Program for Post Intensive Care Syndrome
(ADAPT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new ways to support older adults after they leave the Intensive Care Unit (ICU). The aim is to determine if a special program called Anticipating Decline and Providing Therapy (ADAPT), which includes regular check-ins and cognitive screenings, is more effective than usual follow-up care. It targets individuals aged 60 and older who stayed in the ICU for at least 72 hours and experienced delirium (confusion or disorientation). Participants must have a primary care doctor in the Atrium Health system and be able to speak English. As an unphased trial, this study offers a unique opportunity to contribute to innovative care strategies for older adults.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the ADAPT program is safe for post-ICU patients?
Research has shown that exercise programs like ADAPT can safely and effectively help prevent and manage post-intensive care syndrome (PICS). Studies have found that early rehabilitation, a key component of these programs, improves short-term physical recovery in critically ill patients. Reports indicate no major safety issues with these programs. However, more large studies are needed to fully understand their long-term effects. Overall, patients generally tolerate this kind of therapy well.12345
Why are researchers excited about this trial?
Researchers are excited about the ADAPT Program for Post Intensive Care Syndrome because it takes a proactive approach by anticipating potential cognitive decline in high-risk older adults after an ICU stay. Unlike standard care, which typically involves routine clinic visits, the ADAPT program includes a validated cognitive screening at 6 weeks and 6 months post-ICU discharge. This allows for early identification and management of cognitive issues, potentially improving long-term outcomes for patients. By focusing on early intervention, the program aims to address cognitive challenges before they become severe, offering a more personalized and targeted approach to post-ICU care.
What evidence suggests that this trial's treatments could be effective for Post Intensive Care Syndrome?
Research has shown that many patients experience post-intensive care syndrome (PICS) after leaving the ICU. A review of 36 studies found that non-drug treatments can help with PICS symptoms, such as problems with thinking, memory, and mental health. In this trial, participants will be assigned to one of two groups. The Anticipating Decline and Providing Therapy (ADAPT) program, one of the study arms, aims to help with these symptoms by offering early screening and support for older adults. Meanwhile, the other arm will receive Usual Care, which involves routine clinic visits. Although more large studies are needed, early rehabilitation efforts have shown promise in improving physical health in the short term for critically ill patients. This suggests that ADAPT could effectively support recovery after leaving the ICU.23567
Who Is on the Research Team?
Jessica Palakshappa, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for older adults aged 60 or above who have been discharged from the ICU and may be at risk of post-intensive care syndrome, dementia, or other cognitive impairments. Specific eligibility details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Screening
Participants receive a routine validated cognitive screen at 6 weeks post-ICU discharge
Specialized Care Plan Development
Eligible participants complete a specialized care plan development visit
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Anticipating Decline and Providing Therapy (ADAPT)
- Usual Care post-Intensive Care Unit (ICU)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Institute on Aging (NIA)
Collaborator